Industry News
ZEISS Vision Care Strengthens Myopia Management Portfolio with Acquisition of Brighten Optix
Carl Zeiss Vision International GmbH announced that it has signed a definitive agreement to acquire 100% of the shares in Brighten Optix, a specialist in orthokeratology and specialty contact lenses listed on the Taipei Exchange. The acquisition marks a significant expansion of ZEISS Vision Care’s capabilities in the growing field of myopia management.
Brighten Optix is recognised as a leading provider of orthokeratology (ortho-k) lenses, rigid contact lenses worn overnight to reshape the cornea and temporarily correct myopia. The company’s flagship brands, including the widely used myOK lenses, are known for their innovative design and clinical efficacy. These products are extensively used by eye care professionals and clinics across Greater China and Southeast Asia, where myopia rates among children and adolescents are among the highest globally.
“Progressive myopia is one of the biggest vision care challenges we see in the world today. The topic is so important as the sight of children is at risk. We are already proud of our spectacle lens portfolio, which is clinically proven to significantly slow the progression of myopia. But at the same time, we also know that we need to offer even more options to our partners, the doctors and eye care professionals. That is why we are delighted to have found such a great partner. Our future partnership will allow us to meet exactly this need. We will broaden our portfolio and enable our customers to protect and improve the vision of many more children”, says Sven Hermann, CEO of ZEISS Vision Care and Member of the Executive Board of ZEISS. “Furthermore, Brighten Optix is known for its commitment to research and development. With ZEISS’ heritage of leading innovation, I am confident that this common strength will be of even greater advantage in our joint future”, Hermann concludes.
“We are excited to join a leading, worldwide and visionary company like ZEISS,” says Richard Wu, General Manager of Brighten Optix. “Our business has flourished thanks to pioneering, industry-leading products, and we're eager to capitalize on this chance to help grow and shape the future of vision care and in particular contact lenses and myopia management. Personally, I am proud and thankful to everyone at Brighten Optix for their unwavering commitment and expertise in improving and protecting vision over the last 50 years since my father founded the company. And I am confident that the talented teams of Brighten Optix and ZEISS Vision Care will accomplish great things together”, Wu adds.
The acquisition is expected to close early 2026. The transaction is subject to customary regulatory approvals. Financial terms of the deal were not disclosed.
